Dotmatics' Enterprise Platform Selected by Cancer Therapeutics CRC to Support Collaborative Research Across Multiple Locations in Australia
BISHOPS STORTFORD, UNITED KINGDOM, Jun 01, 2012 (MARKETWIRE via COMTEX) -- Dotmatics Limited, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announced today that, Cancer Therapeutics CRC, have deployed Dotmatics' enterprise platform for data querying and analysis across its multiple research sites. Browser, Dotmatics' enterprise query platform, and Vortex, a premium data visualization and analysis tool, have been implemented by Cancer Therapeutics CRC to enhance data sharing, communication and increase research output. Collaboration is critical for Cancer Therapeutics CRC who operate a collaborative business model with multiple academic, research and industrial partners.
Dotmatics' Vortex is a world-class visualisation and analytics platform designed specifically for analysis and interrogation of scientific data. Vortex provides users with an out-of the-box filtering, charting, plotting and chemically aware calculations engine, enabling scientists to evaluate large datasets in a rich, intuitive and flexible user interface. Browser is a web-based flexible enterprise query and reporting solution for biological and chemical datasets. Browser enables users to query and report data from a variety of 3rd party and disparate data sources. Using a simple web-page interface, Browser gives the power back to the user to create complex reports in a fast and simple way. Both Browser and Vortex are specifically designed for R&D organisations to enable fast and accurate retrieval of research data and thus expedite the drug- discovery process.
"The Browser and Vortex combination is hugely powerful and intuitive to use" said Dr Ian Holmes, Director of Medicinal Chemistry at Cancer Therapeutics CRC. "Despite working on opposite sides of the world the entire setup process was efficient and painless. Dotmatics responded rapidly to issues and were able to instigate specific technical fixes often within a matter of hours" he added.
"We are delighted to deploy our software tools at Cancer Therapeutics CRC. It is great to see how our solutions are being adopted across the world" said Dr Stephen Gallagher, Dotmatics' CEO.
About Dotmatics
Dotmatics has rapidly emerged as a preferred informatics supplier to many of the top global pharmaceutical, biotechnology, and academic organisations. Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies. Dotmatics has significant expertise in chem- and bioinformatics techniques including chemical databases, SAR analysis, data management and data visualization. A privately owned company, Dotmatics was founded in 2005 and has its head office based south of Cambridge, UK.
About Cancer Therapeutics CRC
Cancer Therapeutics CRC is a small molecule drug discovery company that is translating innovative cancer biology research into lead and preclinical stage drug candidates. In particular it is targeting novel cancer pathways associated with the tumour microenvironment or growth, to develop novel treatments for breast, prostate, melanoma, lung and brain cancers.
Contacts:
Enquiries: Dotmatics Limited
Tel (Europe): +44(0)1279 654 123
Tel (US West Coast): +1 (619) 419 2808
Tel (US East Coast): +1 (781) 281 2330
+44(0)1279 653 088 (FAX)
[email protected]
www.dotmatics.com
Dotmatics Limited
The Old Monastery, Windhill
Bishops Stortford, Herts
CM23 2ND, UK
Enquiries:
Cancer Therapeutics CRC
Pty Ltd 4 Research Ave.
Bundoora VIC 3083
Tel: +61 3 9345 2138
www.cancercrc.com
SOURCE: Dotmatics Limited